SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-22-012240
Filing Date
2022-05-12
Accepted
2022-05-12 16:09:37
Documents
78
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm   iXBRL 10-Q 1152467
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 4850
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 4847
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3031
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 3160
  Complete submission text file 0001062993-22-012240.txt   6099417

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igxt-20220331.xsd EX-101.SCH 77515
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igxt-20220331_cal.xml EX-101.CAL 34638
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igxt-20220331_def.xml EX-101.DEF 185017
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igxt-20220331_lab.xml EX-101.LAB 847690
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igxt-20220331_pre.xml EX-101.PRE 323740
72 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 818755
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

IRS No.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31187 | Film No.: 22917856
SIC: 2834 Pharmaceutical Preparations